OBJECTIVE: Children who are fearful and anxious are at heightened risk for developing depression in adolescence. Treating anxiety disorders in pre-/early adolescence may be one mechanism through which depressive symptoms later in adolescence can be prevented. We hypothesized that anxious youth who responded positively to cognitive-behavioral therapy (CBT) for anxiety would show reduced onset of depressive symptoms 2 years later compared to treatment nonresponders, and that this effect would be specific to youth treated with CBT compared to an active supportive comparison treatment. METHOD: Participants were 80 adolescents ages 11 to 17 years who had previously completed a randomized trial comparing predictors of treatment response to CBT and child-centered therapy (CCT). Youth met DSM-IV criteria for generalized, separation, and/or social anxiety disorder at the time of treatment. The present study was a prospective naturalistic 2-year follow-up examining trajectories toward depression, in which participants were reassessed for depressive symptoms 2 years after anxiety treatment. Treatment response was defined as a 35% reduction in independent evaluator-rated anxiety severity on the Pediatric Anxiety Rating Scale after treatment. RESULTS: As hypothesized, lower levels of depressive symptoms were observed in anxious youth who responded to CBT for anxiety (β = -0.807, p = .004) but not CCT (β = 0.254, p = .505). Sensitivity analyses showed that the effects were driven by girls. CONCLUSION: Findings suggest that CBT for anxiety is a promising approach to preventing adolescent depressive symptomatology, especially among girls. The results highlight the need for better early screening for anxiety and better dissemination of CBT programs targeting anxiety in youth.
RCT Entities:
OBJECTIVE:Children who are fearful and anxious are at heightened risk for developing depression in adolescence. Treating anxiety disorders in pre-/early adolescence may be one mechanism through which depressive symptoms later in adolescence can be prevented. We hypothesized that anxious youth who responded positively to cognitive-behavioral therapy (CBT) for anxiety would show reduced onset of depressive symptoms 2 years later compared to treatment nonresponders, and that this effect would be specific to youth treated with CBT compared to an active supportive comparison treatment. METHOD:Participants were 80 adolescents ages 11 to 17 years who had previously completed a randomized trial comparing predictors of treatment response to CBT and child-centered therapy (CCT). Youth met DSM-IV criteria for generalized, separation, and/or social anxiety disorder at the time of treatment. The present study was a prospective naturalistic 2-year follow-up examining trajectories toward depression, in which participants were reassessed for depressive symptoms 2 years after anxiety treatment. Treatment response was defined as a 35% reduction in independent evaluator-rated anxiety severity on the Pediatric Anxiety Rating Scale after treatment. RESULTS: As hypothesized, lower levels of depressive symptoms were observed in anxious youth who responded to CBT for anxiety (β = -0.807, p = .004) but not CCT (β = 0.254, p = .505). Sensitivity analyses showed that the effects were driven by girls. CONCLUSION: Findings suggest that CBT for anxiety is a promising approach to preventing adolescent depressive symptomatology, especially among girls. The results highlight the need for better early screening for anxiety and better dissemination of CBT programs targeting anxiety in youth.
Authors: Autumn Kujawa; Katie L Burkhouse; Shannon R Karich; Kate D Fitzgerald; Christopher S Monk; K Luan Phan Journal: J Child Adolesc Psychopharmacol Date: 2019-05-07 Impact factor: 2.576
Authors: Jennifer S Silk; Stefanie S Sequeira; Neil P Jones; Kyung Hwa Lee; Ronald E Dahl; Erika E Forbes; Neal D Ryan; Cecile D Ladouceur Journal: J Clin Child Adolesc Psychol Date: 2022-01-24
Authors: Rosalind D Butterfield; Jennifer S Silk; Kyung Hwa Lee; Greg S Siegle; Ronald E Dahl; Erika E Forbes; Neal D Ryan; Jill M Hooley; Cecile D Ladouceur Journal: Dev Psychopathol Date: 2021-02
Authors: Elana R Kagan; Hannah E Frank; Lesley A Norris; Sophie A Palitz; Erika A Chiappini; Mark J Knepley; Margaret E Crane; Katherine E Phillips; Golda S Ginsburg; Courtney Keeton; Anne Marie Albano; John Piacentini; Tara Peris; Scott Compton; Dara Sakolsky; Boris Birmaher; Philip C Kendall Journal: Child Psychiatry Hum Dev Date: 2021-02
Authors: Stefanie L Sequeira; Rosalind D Butterfield; Jennifer S Silk; Erika E Forbes; Cecile D Ladouceur Journal: Front Behav Neurosci Date: 2019-09-25 Impact factor: 3.558
Authors: David Villarreal-Zegarra; Rubí Paredes-Angeles; Nikol Mayo-Puchoc; Ana L Vilela-Estada; Anthony Copez-Lonzoy; Jeff Huarcaya-Victoria Journal: BMC Psychiatry Date: 2022-10-10 Impact factor: 4.144
Authors: Stefanie L Sequeira; Jennifer S Silk; Cecile D Ladouceur; Jamie L Hanson; Neal D Ryan; Judith K Morgan; Dana L McMakin; Philip C Kendall; Ronald E Dahl; Erika E Forbes Journal: Am J Psychiatry Date: 2021-01-21 Impact factor: 18.112